GTBIF
Green Thumb Industries Inc.
$7.14
-0.16
(-2.19%)
Mkt Cap
1.66B
Volume
119,789
52W Range
4.8-10.43
Sector
Healthcare
Beta
0.93
EPS (TTM)
0.52
P/E Ratio
13.66
Revenue (TTM)
1.20B
Rev Growth (5Y)
+16.1%
EPS Growth (5Y)
+45.6%
AlphaVal · Fair Value
$15.95
Undervalued · Strong
55.2% below fair value
AlphaQuality · Grade
C
Platform & Compounding FCF
53.1 / 100 composite
Company Description
Green Thumb Industries Inc. engages in manufacture, distribution, and sale of various cannabis products for medical and adult-use in the United States. It offers cannabis flower; and processed and packaged products, including pre-rolls, concentrates, vapes, tinctures, edibles, topicals, and other cannabis-related products under the Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands. The company distributes its products primarily to third-party retail stores, as well as sells finished products directly to consumers in its own retail stores. As of April 11, 2022, it owned and operated 77 retail stores in the United States. The company was founded in 2014 and is headquartered in Chicago, Illinois.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.18B | 1.14B | 1.05B | 1.02B | 893.56M | 556.57M | 216.43M | 62.49M | 16.53M | 7.21M | 0 | 0 |
| Net Income | 116.15M | 73.08M | 36.27M | 11.98M | 75.44M | 14.99M | (59.55M) | (7.86M) | (3.74M) | (979,715) | (3.95M) | (686,796) |
| EPS | 0.49 | 0.31 | 0.15 | 0.05 | 0.33 | 0.07 | -0.31 | -0.06 | -44.81 | -11.99 | -58.10 | -10.99 |
| Free Cash Flow | 213.86M | 115.00M | 4.93M | (20.94M) | (55.80M) | 36.12M | (106.57M) | (34.60M) | (18.75M) | (1.34M) | N/A | N/A |
| FCF / Share | 0.91 | 0.49 | 0.02 | -0.09 | -0.25 | 0.17 | -0.56 | -0.27 | -224.54 | -16.36 | N/A | N/A |
| Operating CF | 294.93M | 195.18M | 224.97M | 158.56M | 132.05M | 95.92M | (18.01M) | (7.11M) | (4.29M) | (206,550) | N/A | N/A |
| Total Assets | 2.79B | 2.54B | 2.49B | 2.43B | 2.39B | 1.36B | 1.17B | 417.00M | 87.16M | 2.60M | N/A | N/A |
| Total Debt | 517.41M | 530.70M | 570.28M | 535.86M | 614.23M | 249.34M | 156.30M | 7.21M | 16.07M | 2.00M | N/A | N/A |
| Cash & Equiv | 274.30M | 171.69M | 161.63M | 177.68M | 230.42M | 83.76M | 46.67M | 145.99M | 29.57M | 151,545 | N/A | N/A |
| Book Value | 1.91B | 1.79B | 1.70B | 1.67B | 1.62B | 910.62M | 840.70M | 345.38M | 62.00M | (185,441) | N/A | N/A |
| Return on Equity | 0.06 | 0.04 | 0.02 | 0.01 | 0.05 | 0.02 | -0.07 | -0.02 | -0.06 | N/A | N/A | N/A |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 300.19M | 311.13M | 291.37M | 293.26M | 279.54M | 294.32M | 286.87M | 280.09M | 274.57M | 285.92M | 275.40M | 252.39M |
| Net Income | 15.18M | 84.48M | 23.03M | (645,000) | 8.31M | 12.68M | 8.62M | 20.71M | 31.08M | 3.22M | 10.51M | 13.40M |
| EPS | 0.07 | 0.36 | 0.10 | -0.00 | 0.04 | 0.05 | 0.04 | 0.09 | 0.13 | 0.01 | 0.04 | 0.06 |
| Free Cash Flow | 56.94M | 75.46M | 56.57M | 37.44M | 44.38M | 16.14M | 29.64M | 405,707 | 69.00M | 34.66M | 6.64M | (46.07M) |
| FCF / Share | 0.25 | 0.33 | 0.24 | 0.16 | 0.19 | 0.07 | 0.13 | 0.00 | 0.29 | 0.15 | 0.03 | -0.19 |
| Operating CF | 75.80M | 90.14M | 74.12M | 56.45M | 74.22M | 43.34M | 47.67M | 20.62M | 83.65M | 72.72M | 60.84M | 18.32M |
| Total Assets | 2.83B | 2.79B | 2.64B | 2.55B | 2.57B | 2.54B | 2.51B | 2.54B | 2.55B | 2.48B | 2.50B | 2.51B |
| Total Debt | 562.37M | 517.41M | 518.06M | 522.74M | 525.81M | 530.70M | 529.70M | 583.54M | 575.37M | 567.37M | 560.38M | 537.18M |
| Cash & Equiv | 346.21M | 274.30M | 235.41M | 176.92M | 210.58M | 171.69M | 173.64M | 196.11M | 223.71M | 160.81M | 136.84M | 149.03M |
| Book Value | 1.90B | 1.91B | 1.83B | 1.79B | 1.81B | 1.79B | 1.77B | 1.75B | 1.75B | 1.69B | 1.71B | 1.71B |
| Return on Equity | 0.01 | 0.04 | 0.01 | -0.00 | 0.00 | 0.01 | 0.00 | 0.01 | 0.02 | 0.00 | 0.01 | 0.01 |
GTBIF News
3 Marijuana Stocks To Know About Now In 2026
Green Thumb Industries vs. Curaleaf Holdings: Which Cannabis Stock Could Win Biggest From DEA Rescheduling?
Green Thumb Just Made an Unprecedented Move. Here's What It Means for GTBIF Investors.
Green Thumb Industries Will Benefit From Medical Cannabis Rescheduling
Green Thumb Industries Inc. (GTBIF) Q1 2026 Earnings Call Transcript
Green Thumb Industries Reports First Quarter 2026 Results
Here Is How Marijuana Stocks Are Setting Up To Run In 2026
Green Thumb Industries Files Applications for DEA Registration Following Historic Rescheduling of Medical Cannabis
2 Medical Marijuana Stocks to Buy Now
Prediction: Green Thumb Industries Stock Will Double Within 3 Years